Get investment to develop and commercialise your biomedical discoveries

The Biomedical Translation Fund (BTF) provides equity co-investment venture capital through licensed private sector fund managers to help develop and commercialise biomedical discoveries into products, services and outcomes that improve health and wellbeing.

At the time of the first investment, you must either be already working on a biomedical discovery or planning to work on a biomedical discovery through a BTF investment.

You should either have a majority of your employees and assets inside Australia or plan to use the whole of the initial investment within Australia.

You must also have an average annual revenue over the previous two years of below $25 million per year, have an Australian business number (ABN), be incorporated under the Corporations Act 2001, and be providing all the goods or services you produce to persons who are not Associates.

The program is delivered through licensed fund managers who make investment decisions; the program does not automatically provide capital to all companies that satisfy the eligible investment criteria.